Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB).
Saved in:
| Title: | Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB). |
|---|---|
| Authors: | Jatoi A (AUTHOR), Dakhil SR (AUTHOR), Sloan JA (AUTHOR), Kugler JW (AUTHOR), Rowland KM Jr (AUTHOR), Schaefer PL (AUTHOR), Novotny PJ (AUTHOR), Wender DB (AUTHOR), Gross HM (AUTHOR), Loprinzi CL (AUTHOR), Jatoi, Aminah1 (AUTHOR), Dakhil, Shaker R (AUTHOR), Sloan, Jeff A (AUTHOR), Kugler, John W (AUTHOR), Rowland, Kendrith M Jr (AUTHOR), Schaefer, Paul L (AUTHOR), Novotny, Paul J (AUTHOR), Wender, Donald B (AUTHOR), Gross, Howard M (AUTHOR), Loprinzi, Charles L (AUTHOR) |
| Source: | Supportive Care in Cancer. Oct2011, Vol. 19 Issue 10, p1601-1607. 7p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09414355 |
|---|---|
| DOI: | 10.1007/s00520-010-0988-5 |
